: Most-Cited Full-Text Articles http://www.cancerbiomed.org Most-cited rankings are recalculated at the beginning of the month based on citations to articles on this journal site from articles in other HighWire-hosted journals. 2026-08-05 <![CDATA[Current cancer burden in China: epidemiology, etiology, and prevention]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/8/1121?rss=1&ssource=mfc Aug 15, 2022; 19:1121-1138
]]> Maomao Cao 2022-08-15 10.20892/j.issn.2095-3941.2022.0231 China Anti-Cancer Association 8 19 1138 2022-08-15 1121 <![CDATA[Epidemiology of ovarian cancer: a review]]> http://www.cancerbiomed.org/cgi/content/short/cbm;14/1/9?rss=1&ssource=mfc Feb 1, 2017; 14:9-32
]]> Brett M. Reid 2017-02-01 10.20892/j.issn.2095-3941.2016.0084 China Anti-Cancer Association 1 14 32 2017-02-01 9 <![CDATA[Roles of Rap1 signaling in tumor cell migration and invasion]]> http://www.cancerbiomed.org/cgi/content/short/cbm;14/1/90?rss=1&ssource=mfc Feb 1, 2017; 14:90-99
]]> Yi-Lei Zhang 2017-02-01 10.20892/j.issn.2095-3941.2016.0086 China Anti-Cancer Association 1 14 99 2017-02-01 90 <![CDATA[Ki-67 as a prognostic marker according to breast cancer molecular subtype]]> http://www.cancerbiomed.org/cgi/content/short/cbm;13/4/496?rss=1&ssource=mfc Dec 1, 2016; 13:496-504
]]> Nahed A. Soliman 2016-12-01 10.20892/j.issn.2095-3941.2016.0066 China Anti-Cancer Association 4 13 504 2016-12-01 496 <![CDATA[The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy]]> http://www.cancerbiomed.org/cgi/content/short/cbm;16/4/655?rss=1&ssource=mfc Nov 1, 2019; 16:655-670
]]> Wenxiao Jia 2019-11-01 10.20892/j.issn.2095-3941.2019.0144 China Anti-Cancer Association 4 16 670 2019-11-01 655 <![CDATA[Early detection of gastric cancer in China: progress and opportunities]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/12/1622?rss=1&ssource=mfc Dec 15, 2022; 19:1622-1628
]]> Hengmin Xu 2022-12-15 10.20892/j.issn.2095-3941.2022.0655 China Anti-Cancer Association 12 19 1628 2022-12-15 1622 <![CDATA[HOTAIR: an oncogenic long non-coding RNA in different cancers]]> http://www.cancerbiomed.org/cgi/content/short/cbm;12/1/1?rss=1&ssource=mfc Mar 1, 2015; 12:1-9
]]> Mohammadreza Hajjari 2015-03-01 10.7497/j.issn.2095-3941.2015.0006 China Anti-Cancer Association 1 12 9 2015-03-01 1 <![CDATA[Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies]]> http://www.cancerbiomed.org/cgi/content/short/cbm;11/1/1?rss=1&ssource=mfc Mar 1, 2014; 11:1-19
]]> Liem Minh Phan 2014-03-01 10.7497/j.issn.2095-3941.2014.01.001 China Anti-Cancer Association 1 11 19 2014-03-01 1 <![CDATA[Next-generation sequencing and its clinical application]]> http://www.cancerbiomed.org/cgi/content/short/cbm;16/1/4?rss=1&ssource=mfc Feb 1, 2019; 16:4-10
]]> Dahui Qin 2019-02-01 10.20892/j.issn.2095-3941.2018.0055 China Anti-Cancer Association 1 16 10 2019-02-01 4 <![CDATA[Personalized immunotherapy in cancer precision medicine]]> http://www.cancerbiomed.org/cgi/content/short/cbm;18/4/955?rss=1&ssource=mfc Nov 1, 2021; 18:955-965
]]> Kazuma Kiyotani 2021-11-01 10.20892/j.issn.2095-3941.2021.0032 China Anti-Cancer Association 4 18 965 2021-11-01 955 <![CDATA[The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview]]> http://www.cancerbiomed.org/cgi/content/short/cbm;16/4/688?rss=1&ssource=mfc Nov 1, 2019; 16:688-699
]]> Francisco Qui&ntilde;onero 2019-11-01 10.20892/j.issn.2095-3941.2019.0252 China Anti-Cancer Association 4 16 699 2019-11-01 688 <![CDATA[Biological and clinical aspects of HPV-related cancers]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/4/864?rss=1&ssource=mfc Nov 15, 2020; 17:864-878
]]> Klaudia Anna Szymonowicz 2020-11-15 10.20892/j.issn.2095-3941.2020.0370 China Anti-Cancer Association 4 17 878 2020-11-15 864 <![CDATA[Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030]]> http://www.cancerbiomed.org/cgi/content/short/cbm;18/3/900?rss=1&ssource=mfc Aug 1, 2021; 18:900-909
]]> Shaoyuan Lei 2021-08-01 10.20892/j.issn.2095-3941.2020.0523 China Anti-Cancer Association 3 18 909 2021-08-01 900 <![CDATA[Metabolic reprogramming in triple-negative breast cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/1/44?rss=1&ssource=mfc Feb 15, 2020; 17:44-59
]]> Zhanyu Wang 2020-02-15 10.20892/j.issn.2095-3941.2019.0210 China Anti-Cancer Association 1 17 59 2020-02-15 44 <![CDATA[Cellular immunotherapy for hematological malignancy: recent progress and future perspectives]]> http://www.cancerbiomed.org/cgi/content/short/cbm;18/4/966?rss=1&ssource=mfc Nov 1, 2021; 18:966-980
]]> Zhengli Xu 2021-11-01 10.20892/j.issn.2095-3941.2020.0801 China Anti-Cancer Association 4 18 980 2021-11-01 966 <![CDATA[Cancer burden in China: trends, risk factors and prevention]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/4/879?rss=1&ssource=mfc Nov 15, 2020; 17:879-895
]]> Dianqin Sun 2020-11-15 10.20892/j.issn.2095-3941.2020.0387 China Anti-Cancer Association 4 17 895 2020-11-15 879 <![CDATA[Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/10/1460?rss=1&ssource=mfc Oct 15, 2022; 19:1460-1476
]]> Kenan Zhang 2022-10-15 10.20892/j.issn.2095-3941.2022.0469 China Anti-Cancer Association 10 19 1476 2022-10-15 1460 <![CDATA[PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy]]> http://www.cancerbiomed.org/cgi/content/short/cbm;15/2/116?rss=1&ssource=mfc May 1, 2018; 15:116-123
]]> Long Jia 2018-05-01 10.20892/j.issn.2095-3941.2017.0086 China Anti-Cancer Association 2 15 123 2018-05-01 116 <![CDATA[Immune checkpoint inhibitors: breakthroughs in cancer treatment]]> http://www.cancerbiomed.org/cgi/content/short/cbm;21/6/451?rss=1&ssource=mfc Jun 15, 2024; 21:451-472
]]> Xueqing Kong 2024-06-15 10.20892/j.issn.2095-3941.2024.0055 China Anti-Cancer Association 6 21 472 2024-06-15 451 <![CDATA[Role of the mechanical microenvironment in cancer development and progression]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/2/282?rss=1&ssource=mfc May 15, 2020; 17:282-292
]]> Qiuping Liu 2020-05-15 10.20892/j.issn.2095-3941.2019.0437 China Anti-Cancer Association 2 17 292 2020-05-15 282 <![CDATA[ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/2/253?rss=1&ssource=mfc May 15, 2020; 17:253-269
]]> Wanjiru Muriithi 2020-05-15 10.20892/j.issn.2095-3941.2019.0284 China Anti-Cancer Association 2 17 269 2020-05-15 253 <![CDATA[Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;15/1/14?rss=1&ssource=mfc Feb 1, 2018; 15:14-28
]]> Muhammad Khairi Ahmad 2018-02-01 10.20892/j.issn.2095-3941.2017.0107 China Anti-Cancer Association 1 15 28 2018-02-01 14 <![CDATA[Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog]]> http://www.cancerbiomed.org/cgi/content/short/cbm;14/2/109?rss=1&ssource=mfc May 1, 2017; 14:109-120
]]> Armel Herve Nwabo Kamdje 2017-05-01 10.20892/j.issn.2095-3941.2016.0032 China Anti-Cancer Association 2 14 120 2017-05-01 109 <![CDATA[COVID-19 in cancer patients: risk, clinical features, and management]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/3/519?rss=1&ssource=mfc Aug 15, 2020; 17:519-527
]]> Cuiwei Liu 2020-08-15 10.20892/j.issn.2095-3941.2020.0289 China Anti-Cancer Association 3 17 527 2020-08-15 519 <![CDATA[Breast cancer screening and early diagnosis in Chinese women]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/4/450?rss=1&ssource=mfc Apr 15, 2022; 19:450-467
]]> Rui Ding 2022-04-15 10.20892/j.issn.2095-3941.2021.0676 China Anti-Cancer Association 4 19 467 2022-04-15 450 <![CDATA[Current approaches in treatment of triple-negative breast cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;12/2/106?rss=1&ssource=mfc Jun 1, 2015; 12:106-116
]]> Hanan Ahmed Wahba 2015-06-01 10.7497/j.issn.2095-3941.2015.0030 China Anti-Cancer Association 2 12 116 2015-06-01 106 <![CDATA[Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies]]> http://www.cancerbiomed.org/cgi/content/short/cbm;20/1/25?rss=1&ssource=mfc Jan 15, 2023; 20:25-43
]]> Changyu Yao 2023-01-15 10.20892/j.issn.2095-3941.2022.0449 China Anti-Cancer Association 1 20 43 2023-01-15 25 <![CDATA[Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment]]> http://www.cancerbiomed.org/cgi/content/short/cbm;20/1/44?rss=1&ssource=mfc Jan 15, 2023; 20:44-55
]]> Pengfei Zhu 2023-01-15 10.20892/j.issn.2095-3941.2022.0491 China Anti-Cancer Association 1 20 55 2023-01-15 44 <![CDATA[Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/1/154?rss=1&ssource=mfc Feb 15, 2020; 17:154-168
]]> Caijun Zha 2020-02-15 10.20892/j.issn.2095-3941.2019.0353 China Anti-Cancer Association 1 17 168 2020-02-15 154 <![CDATA[Current practices and guidelines for clinical next-generation sequencing oncology testing]]> http://www.cancerbiomed.org/cgi/content/short/cbm;13/1/3?rss=1&ssource=mfc Mar 1, 2016; 13:3-11
]]> Samuel P. Strom 2016-03-01 10.28092/j.issn.2095-3941.2016.0004 China Anti-Cancer Association 1 13 11 2016-03-01 3 <![CDATA[Tissue specificity of DNA damage response and tumorigenesis]]> http://www.cancerbiomed.org/cgi/content/short/cbm;16/3/396?rss=1&ssource=mfc Aug 1, 2019; 16:396-414
]]> Siman Sun 2019-08-01 10.20892/j.issn.2095-3941.2019.0097 China Anti-Cancer Association 3 16 414 2019-08-01 396 <![CDATA[Cell cycle regulation and anticancer drug discovery]]> http://www.cancerbiomed.org/cgi/content/short/cbm;14/4/348?rss=1&ssource=mfc Nov 1, 2017; 14:348-362
]]> Jingwen Bai 2017-11-01 10.20892/j.issn.2095-3941.2017.0033 China Anti-Cancer Association 4 14 362 2017-11-01 348 <![CDATA[Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/1/32?rss=1&ssource=mfc Feb 15, 2020; 17:32-43
]]> Yuting Zhang 2020-02-15 10.20892/j.issn.2095-3941.2019.0372 China Anti-Cancer Association 1 17 43 2020-02-15 32 <![CDATA[Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance]]> http://www.cancerbiomed.org/cgi/content/short/cbm;18/2/388?rss=1&ssource=mfc May 1, 2021; 18:388-400
]]> Rui Li 2021-05-01 10.20892/j.issn.2095-3941.2020.0328 China Anti-Cancer Association 2 18 400 2021-05-01 388 <![CDATA[Immunology and immunotherapy in breast cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/5/609?rss=1&ssource=mfc May 15, 2022; 19:609-618
]]> Vladimir Semiglazov 2022-05-15 10.20892/j.issn.2095-3941.2021.0597 China Anti-Cancer Association 5 19 618 2022-05-15 609 <![CDATA[Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy]]> http://www.cancerbiomed.org/cgi/content/short/cbm;20/3/181?rss=1&ssource=mfc Mar 15, 2023; 20:181-195
]]> Tiancheng Zhang 2023-03-15 10.20892/j.issn.2095-3941.2023.0002 China Anti-Cancer Association 3 20 195 2023-03-15 181 <![CDATA[The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/11/1586?rss=1&ssource=mfc Nov 15, 2022; 19:1586-1597
]]> Xuechen Chen 2022-11-15 10.20892/j.issn.2095-3941.2022.0397 China Anti-Cancer Association 11 19 1597 2022-11-15 1586 <![CDATA[The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/4/1002?rss=1&ssource=mfc Nov 15, 2020; 17:1002-1013
]]> Yue Fan 2020-11-15 10.20892/j.issn.2095-3941.2020.0089 China Anti-Cancer Association 4 17 1013 2020-11-15 1002 <![CDATA[Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China]]> http://www.cancerbiomed.org/cgi/content/short/cbm;14/1/33?rss=1&ssource=mfc Feb 1, 2017; 14:33-41
]]> He Liang 2017-02-01 10.20892/j.issn.2095-3941.2016.0093 China Anti-Cancer Association 1 14 41 2017-02-01 33 <![CDATA[Updating targets for natural killer/T-cell lymphoma immunotherapy]]> http://www.cancerbiomed.org/cgi/content/short/cbm;18/1/52?rss=1&ssource=mfc Feb 1, 2021; 18:52-62
]]> Weili Xue 2021-02-01 10.20892/j.issn.2095-3941.2020.0400 China Anti-Cancer Association 1 18 62 2021-02-01 52 <![CDATA[Advances in lung cancer screening and early detection]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/5/591?rss=1&ssource=mfc May 15, 2022; 19:591-608
]]> Caichen Li 2022-05-15 10.20892/j.issn.2095-3941.2021.0690 China Anti-Cancer Association 5 19 608 2022-05-15 591 <![CDATA[Critical protein GAPDH and its regulatory mechanisms in cancer cells]]> http://www.cancerbiomed.org/cgi/content/short/cbm;12/1/10?rss=1&ssource=mfc Mar 1, 2015; 12:10-22
]]> Jin-Ying Zhang 2015-03-01 10.7497/j.issn.2095-3941.2014.0019 China Anti-Cancer Association 1 12 22 2015-03-01 10 <![CDATA[Living biobank-based cancer organoids: prospects and challenges in cancer research]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/7/965?rss=1&ssource=mfc Jul 15, 2022; 19:965-982
]]> Haixin Li 2022-07-15 10.20892/j.issn.2095-3941.2021.0621 China Anti-Cancer Association 7 19 982 2022-07-15 965 <![CDATA[Metabolic regulation of immune responses to cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/11/1528?rss=1&ssource=mfc Nov 15, 2022; 19:1528-1542
]]> Jannis Wi&#223;feld 2022-11-15 10.20892/j.issn.2095-3941.2022.0381 China Anti-Cancer Association 11 19 1542 2022-11-15 1528 <![CDATA[Heterogeneity of neutrophils in cancer: one size does not fit all]]> http://www.cancerbiomed.org/cgi/content/short/cbm;19/12/1629?rss=1&ssource=mfc Dec 15, 2022; 19:1629-1648
]]> Song Chen 2022-12-15 10.20892/j.issn.2095-3941.2022.0426 China Anti-Cancer Association 12 19 1648 2022-12-15 1629 <![CDATA[Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies]]> http://www.cancerbiomed.org/cgi/content/short/cbm;21/10/849?rss=1&ssource=mfc Oct 15, 2024; 21:849-863
]]> Mao Zhang 2024-10-15 10.20892/j.issn.2095-3941.2024.0192 China Anti-Cancer Association 10 21 863 2024-10-15 849 <![CDATA[Drugging the 'undruggable KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;22/7/762?rss=1&ssource=mfc Jul 15, 2025; 22:762-788
]]> Nawaz Khan 2025-07-15 10.20892/j.issn.2095-3941.2025.0122 China Anti-Cancer Association 7 22 788 2025-07-15 762 <![CDATA[Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance]]> http://www.cancerbiomed.org/cgi/content/short/cbm;16/2/264?rss=1&ssource=mfc May 1, 2019; 16:264-275
]]> Nur Syafinaz Zainal 2019-05-01 10.20892/j.issn.2095-3941.2018.0257 China Anti-Cancer Association 2 16 275 2019-05-01 264 <![CDATA[Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGF{beta}1 pathways via off-VEGF signaling]]> http://www.cancerbiomed.org/cgi/content/short/cbm;17/2/418?rss=1&ssource=mfc May 15, 2020; 17:418-432
]]> Xiaoling Zhang 2020-05-15 10.20892/j.issn.2095-3941.2019.0215 China Anti-Cancer Association 2 17 432 2020-05-15 418 <![CDATA[Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer]]> http://www.cancerbiomed.org/cgi/content/short/cbm;20/6/421?rss=1&ssource=mfc Jun 15, 2023; 20:421-437
]]> Mei Feng 2023-06-15 10.20892/j.issn.2095-3941.2023.0019 China Anti-Cancer Association 6 20 437 2023-06-15 421